Sharps Compliance (SMED) Misses Q1 EPS by 2c, Miss on Revenues

Sharps Compliance (NASDAQ: SMED) reported Q1 EPS of $0.00, $0.02 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $9.68 million versus the consensus estimate of $10.26 million.

• Quarterly earnings of $0.1 million versus a prior year quarterly loss of $1.0 million
• Professional market billings increased 10%
• Government and Home Health Care billings increased 23% and 7%, respectively
• Unused Medication solutions billings increased 48%

For earnings history and earnings-related data on Sharps Compliance (SMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c